Drug recall · October 17, 2018
Actoplus met XR recall
Why: Defective Delivery System: tablets may be missing, in whole or in part, the laser drilled holes on the metformin core of the Actoplus met XR tablets.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Actoplus met XR (pioglitazone and metformin HCl, extended-release) tablets, 15 mg/1000 mg, Rx Only, 30 tablet bottle, Distributed by: Takeda Pharmaceuticals America, Inc, Deerfield, IL 60015. NDC: 64764-510-30
- Lots / codes
Lot, expiry: A26004, exp Apr 2020; A26443 and A26444, exp Sep 2020
- Quantity
- 7,248 bottles
- Company
- Takeda Development Center Americas, Inc., Deerfield, IL
- Distribution
- AR, LA, MS, NC, NJ, OH, PA, SC and Puerto Rico
- Initiated
- September 10, 2018 · Voluntary: Firm initiated
- Classified
- October 15, 2018
- Reported
- October 17, 2018
- Ended
- April 13, 2020
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Metformin
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.